Plandai Biotechnology joins up with Phyto Nutricare to fill gap in nutricosmetics market

Plandai Biotechnology, a producer of highly bioavailable plant extracts, has entered into a license agreement with Phyto Nutricare, a UK company, to develop Phytofare extracts for nutricosmetic applications.

On the venture, Plandai CEO Roger Duffield says, "Our foremost goal over the short term is to bring Phytofare products to market. Phyto Nutricare is tasked with introducing our products to market in the nutraceutical arena, which covers cosmetics amongst related fields."

"Botanical extracts are especially prevalent in everything from skin cream to energy drinks. Unfortunately, the way other suppliers produce their extracts results in products that have very little active antioxidant properties and virtually no ability to be absorbed by human tissues."

Furthermore; the CEO reckons that the industry has heretofore been plagued by ingredients that suffer from a lack of bioavailability and that Phytofare supplements in contrast, made from living plant material, "capture the antioxidants while still active".

"We then are able to re-arrange the molecular structure of the catechins and reduce them to nano-particle size, resulting in a product that is vastly more absorbable by human cells. This maximizes the effectiveness of the benefits of green tea and will allow product manufacturers to finally deliver on their health and wellness claims," he adds, on explaining why the recent venture will benefit the cosmetics industry.

Filling a gap in the market

According to Duffield, licensing the development and distribution of Phytofare products for the nutraceutical industry to Phyto Nutricare allows Plandai to focus on the development of new extractions.

Phyto Nutricare have also further cemented the venture by appointing Duffield as its President and Chief Executive Officer whilst he remains on the Board of Directors of Plandai and in the position of Vice President of Sales and Marketing.

His experience in the industry includes working at Johnson and Johnson and has also been involved with the research and development of the Plandai's proprietary emulsions since 2004, working extensively with the USA scientific team.

On his latest appointment; Mr. Baylis-Duffield says; "Our immediate objective is to complete the final product profiling and testing and then formalize our sales and distribution channels so that we are positioned for maximum market penetration once the first product is available. My job is made easier by having extracts that have greater purity, superior anti-oxidant properties and unmatched bioavailability."